Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Cellebrite DI Ltd (NASDAQ: CLBT) closed at $14.2 in the last session, down -1.25% from day before closing price of $14.38. In other words, the price has decreased by -$1.25 from its previous closing price. On the day, 1.42 million shares were traded. CLBT stock price reached its highest trading level at $14.7 during the session, while it also had its lowest trading level at $14.15.
Ratios:
We take a closer look at CLBT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.30 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.45. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on March 28, 2024, Reiterated its Buy rating but revised its target price to $13.50 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on February 16, 2024, whereas the target price for the stock was revised from $9 to $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 23 ’25 when DAVID GEE bought 12,150 shares for $16.71 per share.
DAVID GEE bought 10,555 shares of CLBT for $179,963 on May 21 ’25. On May 20 ’25, another insider, AYALA BERLER SHAPIRA, who serves as the Officer of the company, bought 5,628 shares for $17.02 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLBT now has a Market Capitalization of 3400473856 and an Enterprise Value of 3397063424. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.11 while its Price-to-Book (P/B) ratio in mrq is 9.35. Its current Enterprise Value per Revenue stands at 8.104 whereas that against EBITDA is 48.196.
Stock Price History:
The Beta on a monthly basis for CLBT is 1.28, which has changed by 0.09353614 over the last 52 weeks, in comparison to a change of 0.13161862 over the same period for the S&P500. Over the past 52 weeks, CLBT has reached a high of $26.30, while it has fallen to a 52-week low of $11.90. The 50-Day Moving Average of the stock is -12.96%, while the 200-Day Moving Average is calculated to be -25.41%.
Shares Statistics:
According to the various share statistics, CLBT traded on average about 1.39M shares per day over the past 3-months and 1508770 shares per day over the past 10 days. A total of 239.47M shares are outstanding, with a floating share count of 108.96M. Insiders hold about 54.50% of the company’s shares, while institutions hold 37.04% stake in the company. Shares short for CLBT as of 1749772800 were 1192522 with a Short Ratio of 1.63, compared to 1747267200 on 1805679. Therefore, it implies a Short% of Shares Outstanding of 1192522 and a Short% of Float of 1.0299999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
